# camizestrant

NDC: 63552-290
Generic name: camizestrant
Labeler / Manufacturer: Patheon Manufacturing Services LLC
Product type: DRUG FOR FURTHER PROCESSING
Marketing category: DRUG FOR FURTHER PROCESSING
Dosage form: TABLET, FILM COATED
Routes: —
Marketing started: 20260904



## Active ingredients

- CAMIZESTRANT: 75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63552-290"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63552-290